HK INNO N CORP has a total of 35 patent applications. It increased the IP activity by 533.0%. Its first patent ever was published in 2015. It filed its patents most often in Republic of Korea, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and chemical engineering are ETERNYGEN GMBH, G1 THERAPEUTICS INC and SEED RES INSTITUTE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 8 | |
#2 | EPO (European Patent Office) | 5 | |
#3 | Australia | 4 | |
#4 | Canada | 4 | |
#5 | United States | 4 | |
#6 | Jordan | 3 | |
#7 | Brazil | 2 | |
#8 | Hungary | 1 | |
#9 | Israel | 1 | |
#10 | Serbia | 1 | |
#11 | Taiwan | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Chemical engineering | |
#4 | Machines |
# | Name | Total Patents |
---|---|---|
#1 | Lee Hyuk Woo | 12 |
#2 | Ko Dong Hyun | 10 |
#3 | Kim Eun Sun | 8 |
#4 | Kweon Jae Hong | 8 |
#5 | Kim Dongkyu | 8 |
#6 | Choi Kwang Do | 8 |
#7 | Ki So Young | 8 |
#8 | Lee Sung Ah | 6 |
#9 | Lee Ho-Youl | 6 |
#10 | Kim Seung Chan | 6 |
Publication | Filing date | Title |
---|---|---|
KR20200100552A | Pharmaceutical Composition comprising benzimidazole derivative compound | |
KR20200132283A | Liposome and cosmetic composition comprising the same | |
KR20200095255A | Pharmaceutical composition comprising omega fatty acids, and infusion preparation comprising the same | |
KR20200056652A | Novel compound as a protein kinase inhibitor, and the pharmaceutical composition comprising thereof | |
KR20200044269A | Novel N-(isopropyl-triazolyl)pyridinyl)-heteroaryl-carboxamide derivatives and use thereof | |
KR20200044268A | Novel (isopropyl-triazolyl)pyridinyl-substituted benzooxazinone or benzothiazinone derivatives and use thereof | |
JOP20190201A1 | Composition for eradicating helicobacter pylori | |
JOP20190198A1 | Pharmaceutical composition comprising antiplatelet agent and gastric acid secretion inhibitor |